Saxenda is a brand name for the weight loss injectable medicine, Liraglutide. It was approved by the FDA for weight loss nearly a decade ago. Saxenda has been labeled ‘the skinny jab’ and the ‘miracle ...

Saxenda (liraglutide) is a GLP-1 agonist injection pen medication used to support long-term weight loss in adults with obesity, adults with overweight and weight-related health issues, and certain ...

COPENHAGEN (Reuters) -Novo Nordisk's new obesity drug Wegovy, far more efficient at causing weight loss in patients than similar drugs on the market, could capture sales of its existing obesity ...

Teva's generic Saxenda is the first generic GLP-1 indicated for weight loss. Richardsen added, “This is the fifth first-to-market entry of a Teva generic this year and is an important addition to Teva ...

Share on Pinterest Experts say people should expect to be on weight loss medications for a long period of time. NurPhoto/Getty Images Researchers report that more than half of people on weight loss ...

Credit: FDA. Increased demand for the drug has resulted in supply interruptions. Saxenda (liraglutide) may be in short supply through the end of 2023, according to the Food and Drug Administration’s ...

World Health Organization advisors will meet next month to decide whether liraglutide will be added to the organization’s updated Essential Medicines List, making the drug available in all hospital ...

This undated photo provided by Novo Nordisk shows flags bearing the company's logo. (Novo Nordisk via AP) (Uncredited, © Martin Nordmark) A drug approved to treat ...

Ozempic, the diabetes drug that went viral for its ability to help people lose weight and eat less, is back in the news this week. The EU announced that it would investigate Ozempic and Saxenda (a ...

Risk of some cannibalisation between Wegovy, Saxenda New study data shows sustained weight loss over 2 years Novo will launch Wegovy in the U.S. on June 10 Shares up 0.56% COPENHAGEN, June 7 (Reuters) ...